COVID-19-related hospitalizations among Aotearoa, New Zealand children during the Omicron era of SARS-CoV-2
Amanda Taylor,Emma J Best,Tony Walls,Rachel Webb,Hasan Bhally,Aliya Bryce,Cat L Chang,Kevin Chen,Jack Dummer,Michael Epton,William Good,Jennifer Goodson,Corina Grey,Kate Grimwade,Robert J Hancox,Redzuan Zarool Hassan,Thomas Hills,Sandra Hotu,Colin McArthur,Susan Morpeth,David R Murdoch,Fiona Pease,Romana Pylypchuk,Nigel Raymond,Stephen Ritchie,Debbie Ryan,Vanessa Selak,Malina Storer,Jonathan Williman,Conroy Wong,Karen Wright,Michael J Maze
DOI: https://doi.org/10.1016/j.ijregi.2024.100408
2024-07-20
Abstract:Objectives: This multicenter cohort study describes Aotearoa New Zealand children hospitalized during the country's first wave of sustained SARS-CoV-2 transmission, Omicron variant. Methods: Children younger than 16 years, hospitalized for >6 hours with COVID-19 across New Zealand from January to May 2022 were included. Admissions for all Māori and Pacific and every second non-Maori non-Pacific children were selected to support equal explanatory power for ethnic grouping. Attribution of hospital admission, demography, clinical presentation, comorbidity, treatment, and outcome data were collected. Results: Of 444 hospitalizations of children positive for COVID-19, 292 (65.5%) from 290 children were considered admissions attributable to COVID-19. Of these admissions, 126 (43.4%) were aged under 1; 118 (40.7%), 99 (34.1%), and 87 (30.0%) were children of Māori, Pacific, and non-Maori non-Pacific ethnicity, respectively. Underlying respiratory disease was the most common comorbidity, present in 22 children (7.6%); 16 children (5.5%) were immunosuppressed. Median length of stay was 1 day (interquartile range 0.0-2.0). Four children received antiviral, 69 (24%) antibacterial, and 24 (8%) supplemental oxygen. Although eight children required intensive care, there were no deaths. Conclusions: Children hospitalized during the first significant wave of SARS-CoV-2 infection in New Zealand presented with a multi-system viral illness and rarely with severe disease.